| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
17,491 |
16,046 |
$1.88M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
14,305 |
13,370 |
$1.47M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,519 |
7,700 |
$1.14M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
6,805 |
6,251 |
$241K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,775 |
2,605 |
$187K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
30,680 |
26,017 |
$146K |
| 84484 |
|
6,097 |
4,943 |
$79K |
| 80053 |
Comprehensive metabolic panel |
25,455 |
21,885 |
$77K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,769 |
2,512 |
$74K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
3,361 |
3,073 |
$74K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
709 |
585 |
$68K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,689 |
5,841 |
$67K |
| 87040 |
|
6,309 |
5,127 |
$51K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,015 |
3,254 |
$50K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,034 |
288 |
$47K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,588 |
881 |
$46K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
781 |
706 |
$46K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
575 |
259 |
$41K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
246 |
170 |
$39K |
| 59025 |
Fetal non-stress test |
733 |
578 |
$35K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,645 |
6,089 |
$35K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
3,654 |
3,315 |
$31K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,392 |
3,241 |
$29K |
| 86140 |
|
9,722 |
8,886 |
$25K |
| 85730 |
|
8,560 |
7,651 |
$25K |
| 71045 |
Radiologic examination, chest; single view |
10,019 |
9,008 |
$23K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
6,984 |
6,073 |
$22K |
| 87070 |
|
3,096 |
2,927 |
$21K |
| 83690 |
|
4,679 |
4,308 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
14,606 |
12,264 |
$19K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,226 |
2,003 |
$19K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
923 |
541 |
$18K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
3,183 |
2,874 |
$18K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,532 |
2,268 |
$18K |
| 82150 |
|
4,261 |
3,930 |
$17K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,623 |
3,310 |
$17K |
| 85610 |
|
8,677 |
7,757 |
$17K |
| 97597 |
|
822 |
529 |
$16K |
| 83605 |
|
2,145 |
1,957 |
$10K |
| 81025 |
|
3,439 |
3,017 |
$10K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
52 |
37 |
$9K |
| G0378 |
Hospital observation service, per hour |
82 |
66 |
$7K |
| 93017 |
|
252 |
204 |
$7K |
| 83880 |
|
1,040 |
930 |
$6K |
| 82805 |
|
883 |
764 |
$6K |
| 81003 |
|
8,063 |
7,283 |
$6K |
| 83735 |
|
1,582 |
1,256 |
$5K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
189 |
164 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
85 |
81 |
$5K |
| 87634 |
|
232 |
214 |
$4K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
16 |
15 |
$4K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
192 |
186 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
13 |
13 |
$3K |
| 81001 |
|
4,305 |
4,024 |
$3K |
| 93226 |
|
103 |
88 |
$3K |
| 86850 |
|
310 |
261 |
$3K |
| 36600 |
|
839 |
727 |
$3K |
| 87807 |
|
342 |
333 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
631 |
594 |
$3K |
| 84145 |
|
331 |
302 |
$2K |
| 93225 |
|
95 |
79 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
356 |
331 |
$2K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
46 |
38 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
433 |
208 |
$1K |
| 82728 |
|
297 |
263 |
$1K |
| 86900 |
|
348 |
287 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
177 |
172 |
$1K |
| 86901 |
|
343 |
284 |
$1K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
169 |
152 |
$1K |
| 87186 |
|
245 |
215 |
$953.11 |
| 36591 |
|
113 |
63 |
$914.85 |
| 80061 |
Lipid panel |
351 |
327 |
$733.82 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
132 |
124 |
$726.07 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
50 |
45 |
$717.31 |
| 76830 |
Ultrasound, transvaginal |
15 |
13 |
$677.88 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
316 |
262 |
$616.10 |
| 82570 |
|
181 |
163 |
$571.95 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
51 |
36 |
$437.34 |
| 73630 |
|
56 |
50 |
$402.78 |
| 74021 |
|
77 |
69 |
$338.28 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
336 |
223 |
$308.96 |
| 87400 |
|
44 |
43 |
$209.17 |
| 85379 |
|
56 |
53 |
$202.90 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
77 |
65 |
$192.95 |
| 87077 |
|
27 |
25 |
$90.79 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
46 |
37 |
$82.75 |
| 84439 |
|
29 |
28 |
$79.46 |
| 74019 |
|
12 |
12 |
$59.91 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13 |
13 |
$58.65 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
97 |
94 |
$54.10 |
| 83550 |
|
16 |
12 |
$51.09 |
| 83540 |
|
28 |
24 |
$44.64 |
| 86308 |
|
12 |
12 |
$37.73 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
218 |
164 |
$18.37 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
172 |
121 |
$9.44 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,782 |
1,587 |
$9.31 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,214 |
2,910 |
$5.59 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,148 |
1,001 |
$0.01 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,973 |
1,779 |
$0.00 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
186 |
163 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
184 |
128 |
$0.00 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
87 |
57 |
$0.00 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
286 |
193 |
$0.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
49 |
36 |
$0.00 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
86 |
57 |
$0.00 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
21 |
12 |
$0.00 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
15 |
12 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
817 |
643 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
164 |
121 |
$0.00 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
25 |
24 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
12 |
12 |
$0.00 |